CCO Treatment Updates
Allogeneic Transplantation: Applying New Research for Improved Outcomes
|
Whether you treat patients with transplantable disorders or perform hematopoietic transplantation, these CME-certified programs provide an efficient way to hear the latest review in allogeneic transplantation today. In these sessions, you will receive information you can use to aid in clinical decision-making. Learn when transplant should be considered, what factors influence outcomes, the effect of age on patient eligibility, and recent advances in HLA matching.
This program is produced in partnership with the National Marrow Donor Program (NMDP). The NMDP facilitates unrelated donor transplants, conducts research, provides medical education, and patient support.
Access clinical guidelines, outcomes data, and patient education resources on the National Marrow Donor Program’s Physician Resource Center at marrow.org/md
|
Virtual Presentations
Comparing Outcomes of Related and Unrelated Transplantations
|
|
|
Claudio Anasetti, MD, summarizes research that compares outcomes of related and unrelated donor transplants.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe factors that may result in lower survival from human leukocyte antigen (HLA)–matched unrelated donor transplantation vs sibling donor
- Explain the effect of recipient cytogenetics on unrelated donor transplantation outcomes
- Discuss strategies to reduced graft-vs-host disease and the effect these have had on HLA-matched unrelated donor transplantations
|
Slideset: Comparing Outcomes of Related and Unrelated Transplants
 |
|
Download slides in which Claudio Anasetti, MD compares outcomes from related and unrelated HLA-matched allogeneic stem cell transplantation.
Format: Microsoft PowerPoint (.ppt) |
File size: 3.42 MB
| Date posted: 7/14/2009
|
Transplantation from Unrelated Donors: Factors That Influence Outcomes and Graft Choices
|
|
|
Mary Horowitz, MD, explains the influence of patient and donor factors on unrelated transplant outcomes.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Explain why HLA-mismatched donors may be options for patients requiring hematopoietic cell transplantation
- Describe the effects of mismatching at various HLA loci
- Understand how differences between equivalently HLA-matched donors affect outcomes in hematopoietic cell transplantation
|
Slideset: Transplantation from Unrelated Donors: Factors That Influence Outcomes – and Graft Choices
 |
|
Download slides in which Mary Horowitz, MD explains which donor and recipient factors affect outcomes in hematopoietic stem cell transplantations from unrelated donors
Format: Microsoft PowerPoint (.ppt) |
File size: 2.12 MB
| Date posted: 7/14/2009
|
Advances in HLA Matching for Unrelated Donor Transplantation
|
|
|
Dennis L. Confer, MD, explains advances in HLA typing including clinical and technology innovations.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Distinguish between low-, intermediate-, and high-resolution HLA DNA typing
- Describe issues in HLA typing that complicate finding an HLA-matched donor
- Describe the use of haplotypes in HLA matching and matching marrow donors to patients
|
Slideset: Advances in HLA Matching for Unrelated Donor Transplantation
 |
|
Download slides in which Dennis L. Confer, MD, explains the work of the National Marrow Donor Program and describes advances in HLA typing.
Format: Microsoft PowerPoint (.ppt) |
File size: 5.29 MB
| Date posted: 7/13/2009
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
In association with and an educational grant provided by:
Educational grants support only the CME-certified components of this program.
|